Life Sciences (Biotech and Pharma R&D)
Register (ga4gh service registry, elixir bio.tools, identifiers.org). The Kin Score Market layer reads each provider in its market: who it integrates with, how deep those integrations go, and where the market publishes its own structure. Methodology.
Where this market publishes its structure
- GA4GH Service Registry, registry.ga4gh.org/v1/services + /v1/implementations (organization name + url, service url, type.artifact) machine-readable
- ELIXIR bio.tools, toolType "Web API" (homepage, credit name/url/email, EDAM topics) machine-readable
- identifiers.org resolver dataset (namespace resources: institution name + homeUrl, resource home, urlPattern) machine-readable
- openFDA drugsfda sponsor_name / device registrationlisting owner_operator not machine-readable: JSON and keyless, but carries no domain (firm name, address, phone only); the domain-only rule refuses name matching (2026-10-15)
- Beacon Network registry (beacon-network.elixir-europe.org) not machine-readable: no response on /api/services (2026-10-15); GA4GH registry's own Beacon service-registry entries were read instead
- Allotrope Foundation members / Pistoia Alliance members / Benchling marketplace not machine-readable: member and partner pages are HTML lists of logos, no machine-readable register (2026-10-15)
Own = declares at least one integration itself; covered = visible only because an aggregator, standards body, regulator or partner contract names it; distribution-only = listed only on cloud marketplaces it sells through, a channel reported beside, never counted as its own declared integrations; undeclared = nothing we can read, so no number; declares_compatibility = providers with a `compatible` shape vote, report only (kin, 2026-10-13): never counted as own, never in depth or position.
Taxonomy how this market maps onto apis.io
Derived 2026-10-23 from the 41 providers in this market we could resolve in the catalog. The percentage is the share of those providers carrying each one; it describes the market, not the tag or industry. Tag groups have no page of their own yet, so they are listed unlinked.
| Tags | Life Sciences 61%, Healthcare 44%, Genomics 37%, Bioinformatics 32% |
|---|---|
| Tag groups | Healthcare 90%, Health 29%, Education 27% |
| Industries | Biotechnology & Drug Discovery 61%, Life Sciences 61%, Healthcare 49%, Digital Health & Telehealth 27%, Pharmaceutical 24% |
share of resolved cohort carrying it; tags >=0.20 & >=3 members (max 12, junk dropped), tag_groups >=0.20 (cooccurrence, non-cross-cutting; max 8), industries >=0.20 (max 6), areas >=0.10 (max 6; areas are keyword-matched and sparse), capabilities L1 >=0.20 (max 8); derive-market-taxonomy.py
Leaders by position (provisional)
Provisional: grouped by position, depth compared within a position only. Distribution (cloud marketplaces) and iPaaS bridges are counted beside position, never inside it. Unknown-builder listings are left out of position shares and counted here.
builds-on 4 · publishes apps on other platforms' stores
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Authenticx | 53.9 | 3 | 0 / 3 | 0 | 0 | 0 | standard 33%, builds-on-platform 67% |
| Benchling | 46.0 | 4 | 0 / 4 | 0 | 1 | 0 | standard 25%, builds-on-platform 50%, distribution 25% |
| Seqera Labs | 34.9 | 4 | 0 / 4 | 0 | 1 | 1 | ipaas-bridge 25%, builds-on-platform 50%, distribution 25% |
| Aignostics | 26.8 thin | 2 | 0 / 2 | 0 | 2 | 0 | builds-on-platform 33%, distribution 67% |
regulated 4 · named in a regulator's register or partners' contracts
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Illumina | 51.4 | 9 | 0 / 9 | 0 | 1 | 1 | ipaas-bridge 11%, contract 56%, standard 22%, distribution 11% |
| DNAnexus | 46.9 | 7 | 0 / 7 | 0 | 3 | 0 | contract 29%, standard 29%, distribution 43% |
| Datavant | 46.7 | 4 | 0 / 4 | 0 | 2 | 0 | contract 50%, distribution 50% |
| Seven Bridges | 38.8 thin | 2 | 0 / 2 | 0 | 0 | 0 | contract 50%, standard 50% |
standard 14 · listed by a voluntary standard's own directory
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Optum | 53.0 | 12 | 0 / 12 | 0 | 3 | 0 | contract 7%, standard 57%, builds-on-platform 14%, distribution 21% |
| Clarivate | 50.1 | 6 | 0 / 6 | 0 | 1 | 0 | contract 17%, standard 50%, builds-on-platform 17%, distribution 17% |
| Ensembl | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Food and Drug Administration | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| National Institutes of Health | 34.5 thin | 2 | 0 / 2 | 0 | 0 | 0 | standard 100% |
| Cdisc | 26.8 thin | 2 | 0 / 2 | 0 | 1 | 0 | standard 50%, distribution 50% |
| Cancer.gov | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| ClinicalTrials.gov | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| National Library of Medicine | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| National Center for Biotechnology Information (NCBI) | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| National Institutes of Health (NIH) | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| Particle Health | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| UniProt | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
| United States National Library of Medicine | 17.2 thin | 1 | 0 / 1 | 0 | 0 | 0 | standard 100% |
long-tail 1 · reached only through iPaaS bridges
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| Veeva | 2.5 thin | 1 | 0 / 1 | 0 | 0 | 1 | ipaas-bridge 100% |
distribution 5 · only sells through cloud marketplaces
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| TileDB | 28.7 | 4 | 0 / 4 | 0 | 4 | 0 | distribution 100% |
| Gencove | 9.6 thin | 1 | 0 / 1 | 0 | 2 | 0 | distribution 100% |
| One Codex | 9.6 thin | 1 | 0 / 1 | 0 | 1 | 0 | distribution 100% |
| QC Ware | 9.6 thin | 1 | 0 / 1 | 0 | 1 | 0 | distribution 100% |
| TraceLink | 9.6 thin | 1 | 0 / 1 | 0 | 1 | 0 | distribution 100% |
undeclared 13 · declares nothing we can read: no number
| Provider | Depth | Integrations | In / out | Unknown builder | Distribution | iPaaS bridge | Mix |
|---|---|---|---|---|---|---|---|
| 10x Genomics | undeclared | - | - | - | - | - | |
| Amazon HealthOmics | undeclared | - | - | - | - | - | |
| ChEMBL | undeclared | - | - | - | - | - | |
| DoseSpot | undeclared | - | - | - | - | - | |
| openFDA | undeclared | - | - | - | - | - | |
| Photon | undeclared | - | - | - | - | - | |
| Prezent | undeclared | - | - | - | - | - | |
| Qualio | undeclared | - | - | - | - | - | |
| Tellius | undeclared | - | - | - | - | - | |
| TetraScience | undeclared | - | - | - | - | - | |
| Truepill | undeclared | - | - | - | - | - | |
| UCSC Genomic Data | undeclared | - | - | - | - | - | |
| xCures | undeclared | - | - | - | - | - |
Generated 2026-10-24 from API Evangelist's own files; nothing on this page is a model's judgement. Provisional and unweighted; not part of the Kin Score composite or agent readiness. Read the Market layer methodology. Disagree with an edge? Every edge cites its evidence and can be corrected through the normal correction path.